Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …

Objective Approximately one third of individuals worldwide have not received a COVID‐19
vaccine. Although studies have investigated risk factors linked to severe COVID‐19 among …

Background/objective This study aims to describe the course and to identify poor prognostic
factors of SARS-CoV-2 infection in patients with rheumatic diseases. Methods Patients≥ 18 …

Background Over the years, air pollution has garnered increased attention from researchers
who continue to provide studies and suggestive data that prove there is an ever-increasing …

SARS-CoV-2 and its variants are widely prevalent worldwide. With frequent secondary and
breakthrough infections, immune dysfunction in RA patients, and long-term use of immune …

Objective Autoimmune or inflammatory rheumatic diseases (AIRDs) increase the risk for
poor COVID‐19 outcomes. Although rurality is associated with higher post–COVID‐19 …

Objectives This study aims to quantify the relationship between societal volunteering and the
impact of COVID-19 in that society. Design Cross-sectional study. Setting, participants and …

Systemic lupus erythematosus (SLE) affects more severely non-White populations, which is
also the case in Latin America; this is the result of a combination of genetic and non-genetic …

Systemic lupus erythematosus (SLE) affects more severely non-White populations, which is
also the case in Latin America; this is the result of a combination of genetic and non-genetic …

Introduction/objectives The understanding of COVID-19 progression among patients with
autoimmune rheumatic diseases (SARDs) in Latin America remains limited. This study …